**Core Concept**
Retinoblastoma is a malignant tumor of the retina, primarily affecting children. The treatment of retinoblastoma often involves chemotherapy, which aims to preserve vision while eradicating the cancer cells. The chemotherapy agents used in retinoblastoma are typically alkylating agents or antimetabolites that target rapidly dividing cells.

**Why the Correct Answer is Right**
The chemotherapy agents used for retinoblastoma include Carboplatin, Vincristine, and Etoposide. Carboplatin is an alkylating agent that intercalates into DNA, causing cross-linking and DNA damage, ultimately leading to cell death. Vincristine is an antimicrotubule agent that inhibits microtubule formation, disrupting cell division and causing apoptosis. Etoposide is a topoisomerase inhibitor that blocks the action of topoisomerase II, leading to DNA damage and cell death. These agents are often used in combination to achieve optimal tumor response.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a valid chemotherapy agent used in retinoblastoma treatment.
**Option B:** This option is incorrect because it is not a commonly used chemotherapy agent in retinoblastoma treatment.
**Option C:** This option is incorrect because it is not a standard chemotherapy agent used in retinoblastoma treatment.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that chemotherapy agents used in retinoblastoma often involve a combination of alkylating agents and antimicrotubule agents to achieve optimal tumor response. This combination can help preserve vision while eradicating cancer cells.

**Correct Answer:** A. Carboplatin.